Table 3.
Effect sizes (ES) weighted by participant.
| Primary study | Meta-analysis participant no. | Treated items |
Untreated items |
||
|---|---|---|---|---|---|
| Treatment phase ES | Follow-up phase ES | Treatment phase ES | Follow-up phase ES | ||
| Wambaugh, Kalinyak-Fliszar, et al. (1998) | 1 | 6.30 | 6.53 | 8.00 | 6.25 |
| Wambaugh, Kalinyak-Fliszar, et al. (1998) | 2 | 7.01 | 6.08 | 7.51 | 11.32 |
| Wambaugh, Kalinyak-Fliszar, et al. (1998) | 3 | 3.24 | 10.31 | 4.11 | 7.39 |
| Wambaugh, West, et al. (1998) | 4 | 5.79 | 5.27 | 5.44 | 6.43 |
| Wambaugh & Cort (1998) | 5 | 3.90 | — | 3.62 | — |
| Wambaugh et al. (1999) | 6 | 17.44 | 14.17 | 10.96 | 12.67 |
| Wambaugh (2004) | 7 | 5.30 | 11.42 | 3.27 | 7.50 |
| Wambaugh (2004) | 8 | 5.17 | 4.58 | 3.72 | 3.40 |
| Wambaugh & Nessler (2004) | 9 | 5.07 | 6.05 | — | — |
| Wambaugh & Mauszycki (2010) | 10 | 6.76 | 7.12 | 3.75 | 3.99 |
| Wambaugh et al. (2013) | 11 | 8.77 | 5.74 | 2.24 | 3.87 |
| Wambaugh et al. (2013) | 12 | 7.19 | 5.66 | 2.25 | 2.13 |
| Wambaugh et al. (2013) | 13 | 22.00 | 10.73 | 3.89 | 4.47 |
| Wambaugh et al. (2013) | 14 | 6.95 | 7.08 | 3.03 | 2.59 |
| Wambaugh et al. (2014) | 15 | 4.36 | 5.29 | 1.01 | 1.53 |
| Wambaugh et al. (2014) | 16 | 10.72 | 10.06 | 5.81 | 5.34 |
| Wambaugh et al. (2014) | 17 | 14.76 | 9.66 | 4.21 | 2.92 |
| Wambaugh et al. (2014) | 18 | 14.47 | 11.08 | 8.61 | 5.48 |
| Wambaugh et al. (2014) | 19 | 9.02 | 11.42 | 8.93 | 7.06 |
| Wambaugh et al. (2014) | 20 | 8.19 | 8.01 | 9.21 | 6.47 |
| Wambaugh et al. (in press) | 21 | 4.91 | 6.11 | 0.85 | 1.58 |
| Wambaugh et al. (in press) | 22 | 5.54 | 7.86 | 1.92 | 2.95 |
| Wambaugh et al. (in press) | 23 | 9.38 | 10.02 | 1.05 | 2.56 |
| Wambaugh et al. (in press) | 24 | 9.93 | 4.47 | 1.14 | 1.80 |
Note. All values are given in standard deviation units. Em dashes indicate necessary phase data not collected in the original study.